Myocardial Viability

1. Front Matter

   Pages i-xi

   PDF

2. Hibernating and stunned myocardium: Pathophysiological considerations

   • Markus Schwaiger, Ulrich Schricke

   Pages 1-20

3. Role of apoptosis in myocardial hibernation and myocardial stunning

   • Ragavendra R. Baliga, Jutta Schaper, Jagat Narula

   Pages 21-45

4. Assessment of myocardial viability with positron emission tomography

   • Heinrich R. Schelbert

   Pages 47-72

5. Assessment of myocardial viability by thallium-201

   • Jeroen J. Bax, Jean-Louis J. Vanoverschelde, Ernst E. Van Der Wall

   Pages 73-89

6. Technetium-99m-labeled perfusion tracers for the detection of myocardial viability

   • Roberto Sciagrà

   Pages 91-112

7. Fatty-acid SPECT imaging for assessment of myocardial viability

   • Mario S. Verani

   Pages 113-129

8. Role of FDG SPECT in viability assessment

   • Jeroen J. Bax, Frans C. Visser, Ernst E. Van Der Wall

   Pages 131-145

9. Detection of myocardial viability by angiographic methods

   • William Wijns

   Pages 147-154

10. Echocardiographic assessment of reversible left ventricular dysfunction

    • Farooq A. Chaudhry, Kathleen Galatro

    Pages 155-175

11. Role of magnetic resonance techniques in viability assessment

    • Ernst E. Van Der Wall, Jeroen J. Bax, Hubert W. Vliegen, Albert V. G. Bruschke, Albert De Roos

    Pages 177-197

12. Viability assessment: clinical applications

    • Ami E. Iskandrian

    Pages 199-227

13. Summary

    • Ami S. Iskandrian, Ernst E. Van Der Wall

    Pages 229-231

14. Back Matter

    Pages 233-244

    PDF

AMI E. ISKANDRIAN & ERNST E. VAN DER WALL The first edition of this book was published in 1994. Since then important advances have occurred in the field of myocardial viability. This, coupled with increasing interest by the scientific community in the broader issues of its relevance to patient care, suggested to us the need to write the second edition. We are most fortunate to have the help of a distinguished group of experts who have helped shape the field; we appreciate their commitments and contributions. Almost all chapters have been radically modified. Chapter 1 deals with pathophysiology of myocardial hibernation and stunning; Chapter 2 with apoptosis; Chapter 3 with the role of positron emission tomography; Chapters 4 and 5 with the role of single photon emission computed tomography with thallium-201 and technetium agents, respectively; Chapter 6 with the role of SPECT fatty acid imaging; Chapter 7 with the role of SPECT FDG imaging; Chapter 8 with the role of cardiac catheterization angiography; Chapter 9 with the role of echocardiography; Chapter 10 with the role of magnetic resonance imaging; and Chapter 11 with clinical applications. Finally, Chapter 12 provides a short summary.

• SPECT
• drugs
• magnetic resonance
• tomography
• transplantation

`...the coverage of the various modalities is quite comprehensive. The book is very well referenced and contains plenty of figures and tables... This volume will appeal to cardiologists, echocardiographers, nuclear physicians, surgeons and others and would make a useful acquisition to an institutional library.'
ANZ Nuclear Medicine, 32:1 (2001)

• Nuclear Cardiology, Division Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, USA

  Ami E. Iskandrian

• Department of Cardiology, Leiden, University Medical Center, Leiden, The Netherlands

  Ernst E. Wall

Policies and ethics